Skip links

Case Study

Infusing Agility in a Large Investment Bank for Faster Time-to-Market

Platform-as-a-Service increases resiliency and scalability.

A large US-based investment bank partnered with Altimetrik to reduce operational overhead and improve the productivity of their application development teams by reducing back-end plumbing requirements for new applications. The game plan here was to infuse agility – one of the core transformation capabilities that Altimetrik brings to the table for clients.

Using platform engineering principles and Altimetrik best practices, the team created the solution architecture for a platform leveraging a PAAS layer that enabled seamless interaction of applications and reduced cycle production times. The platform significantly improved the operational efficiency of the client’s development teams and time-to-market, with zero downtime.

  • 10% Higher Operational Efficiency
  • 15% Faster Time-to-market
  • 100% Uptime with Monitoring and Site Reliability Capabilities
  • Zero Downtime Deployments for System Updates

New deployment results in 100% uptime and increased agility and scalability.

Altimetrik built and deployed a Service Orchestration engine as a PAAS layer. By enabling runtime consumption core application-infrastructure services via APIs, Altimetrik allowed the bank’s systems to evolve continuously and eliminated end-of-life constraints.

Altimetrik transformed the client’s application development backend with the following steps:

  • Developed a REST-based engine for container deployment and orchestration
  • Migrated existing APIs to Golang APIs for adoption to REST-based engine platform
  • Created Kibana-based dashboards for real-time Log Analytics
  • Configured AppDynamics for container metrics
  • Configured Prometheus for service operational metrics and Sysdig for site reliability dashboards

“Time-to-market and production readiness are two important facets of keeping a business sharp and agile in the digital age where customers are always making decisions based on their digital experiences. Investment banks have to be at par with retail banking in providing a seamless digital experience to customers. Altimetrik’s platform engineering capability can completely transform the way applications are handled by banks to bring in speed, agility and accuracy.”

Ranga Kanapathy

Head of Engineering

Digital Business Methodology

The Growth Code

We give you the DBM Growth Code: A step-by-step guide written by practitioners to help you accelerate digital business.

Latest Insights

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes